Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Sympathetic nervous system (SNS) hyperactivity is a salient characteristic of chronic heart failure (HF) and contributes to the progression of the disease. Iodine-123 meta-iodobenzylguanidine (I-mIBG) imaging has been successfully used to assess cardiac SNS activity in HF patients and to predict prognosis. Importantly, SNS hyperactivity characterizes also physiological ageing, and there is conflicting evidence on cardiac I-mIBG uptake in healthy elderly subjects compared to adults. However, little data are available on the impact of ageing on cardiac sympathetic nerve activity assessed by I-mIBG scintigraphy, in patients with HF.

Methods And Results: We studied 180 HF patients (age = 66.1 ± 10.5 years [yrs]), left ventricular ejection fraction (LVEF = 30.6 ± 6.3 %) undergoing cardiac I-mIBG imaging. Early and late heart to mediastinum (H/M) ratios and washout rate were calculated in all patients. Demographic, clinical, and echocardiographic data were also collected. Our study population consisted of 53 patients aged >75 years (age = 77.7 ± 4.0 year), 67 patients aged 62-72 years (age = 67.9 ± 3.2 years) and 60 patients aged ≤61 year (age = 53.9 ± 5.6 years). In elderly patients, both early and late H/M ratios were significantly lower compared to younger patients (p < 0.05). By multivariate analysis, H/M ratios (both early and late) and washout rate were significantly correlated with LVEF and age.

Conclusions: Our data indicate that, in a population of HF patients, there is an independent age-related effect on cardiac SNS innervation assessed by I-mIBG imaging. This finding suggests that cardiac I-mIBG uptake in patients with HF might be affected by patient age.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-016-3432-3DOI Listing

Publication Analysis

Top Keywords

i-mibg imaging
12
patients aged
12
patients
10
cardiac sympathetic
8
heart failure
8
sns hyperactivity
8
cardiac i-mibg
8
early late
8
h/m ratios
8
cardiac
5

Similar Publications

A PET analog of metaiodobenzylguanidine (MIBG)-F-metafluorobenzylguanidine (F-MFBG)-allows for rapid same-day imaging. We previously reported on the safety and feasibility of F-MFBG PET imaging in patients with neuroendocrine tumors. We now report a comprehensive analysis of lesion detection with F-MFBG imaging in patients with neuroblastoma compared with I-MIBG imaging.

View Article and Find Full Text PDF

Background: Congenital neuroblastoma represents an early-onset form of neuroblastoma. This study aims to evaluate the imaging features of I-metaiodobenzylguanidine (I-MIBG) single-photon emission computed tomography (SPECT)/computed tomography (CT) and their correlation with the clinical characteristics of localized congenital neuroblastoma.

Methods: We retrospectively collected imaging and clinical data from congenital neuroblastoma patients who underwent I-MIBG SPECT/CT.

View Article and Find Full Text PDF

Background: High-risk neuroblastoma (NB) is characterized by its resistance to treatment and high recurrence rate. Accurate imaging diagnostic methods can improve prognosis. As an emerging and promising diagnostic tool, the comparative diagnostic value of F-AlF-NOTA-octreotide (F-OC) positron emission tomography/computed tomography (PET/CT) versus the existing I-meta-iodobenzylguanide (I-MIBG) single-photon emission computed tomography/computed tomography (SPECT/CT) in assessing treatment response and monitoring recurrence of NB requires further investigation.

View Article and Find Full Text PDF

Purpose: Left ventricular (LV) mechanical synchrony is essential for efficient cardiac function, and its disruption (dyssynchrony) negatively impacts outcomes, particularly in heart failure. Although sympathetic innervation modulates electrical activation and contraction timing, its relationship with mechanical synchrony is underexplored. This study aimed to assess their association using echocardiographic synchrony indices and I-mIBG scintigraphy, introducing a novel index (AMP-sync).

View Article and Find Full Text PDF

[F]MFBG PET/CT is an effective and preferable imaging modality for neuroblastoma in a prospective comparison with SSTR PET.

Eur J Nucl Med Mol Imaging

July 2025

Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang Province, China.

Purpose: [F]-meta-fluorobenzylguanidine ([F]MFBG) and somatostatin receptor (SSTR)-targeted PET tracers have both been proposed for imaging neuroblastoma, however, their respective clinical roles remain unclear. This prospective study compared [F]MFBG PET with SSTR-targeted PET, using either [Ga]Ga-DOTATATE or [F]AlF-NOTA-octreotide([F]-OC), to evaluate diagnostic performance and potential clinical impact in neuroblastoma.

Methods: Sixteen patients (median age 5.

View Article and Find Full Text PDF